USPTO serial 79378653
XEPIXLIFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 4, 2025
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XEPIXLIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Turgeon
Michael J. Turgeon Vedder Price P.C.222 North LaSalle StreetSuite 2500Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Genetic mapping for scientific purposes; Scientific research in the field of genetics; Scientific research in the field of genetics and epigenetics; genetic fingerprinting services; genetic testing for scientific research purposes; scientific research in the field of genetics; scientific research in the field of genetics and the genetic engineering; biotechnology testing in the nature of testing of pharmaceuticals; research in the field of biotechnology; consulting services in the field of biotechnology; research and development in the field of pharmacy and biotechnology; research and development in the field of biotechnology; providing information on scientific research in the field of biochemistry and biotechnology; design of process systems for use in the biotechnology industry; scientific and technological services namely scientific research, analysis, testing in the field of pharmacy, biochemistry and biotechnology; medical research and pharmaceutical research services; consultancy relating to laboratory testing of materials; cell culture services for scientific and research purposes for others; medical and scientific research namely conducting clinical trials for others; providing information on clinical studies via an interactive website; biological research; basic and clinical research in the field of genetic and epigenetics; medical research services; scientific research with a medical purpose in the field of genetics and epigenetics; medical research services; scientific research and development; cell culture services for scientific or research purposes, for third parties; biomedical research services; medical laboratory research services relating to dermatology; medical research laboratory services; providing information about clinical studies via an interactive website; stem cell research services; cell separation technology research services; scientific research in the field of cellular engineering technology; scientific research and development in the fields of microorganisms and cells; scientific services for the isolation and cultivation of human tissues and cells | ACTIVE | — |
| 044 | Genetic testing for medical purposes; genetic testing for medical purposes, in particular epigenetic analysis; genetic counseling; consultancy and advisory services relating to beauty services; food nutrition consultancy; health care services, namely, advice regarding nutrition; nutritional advisory services; dietary and nutritional guidance; nutrition and dietetic advisory services; advice concerning diet and nutrition; professional consultancy regarding nutrition; provision of information relating to nutrition; provision of nutritional information regarding food products; providing information regarding dietary and nutritional supplements; providing information relating to dietary and nutritional guidance; provision of information concerning dietetic and nutritional supplements; medical services relating to the removal, treatment and processing of stem cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 4, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 12, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 4, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 4, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 18, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 15, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |